Thermo Fisher Acquires IntegenX

Thermo Fisher Scientific has acquired IntegenX Inc, which provides a rapid DNA platform for use in forensics and law enforcement applications. IntegenX products significantly enhance Thermo Fisher’s existing HID portfolio and complement its leading human identification chemistries, as well as its qPCR and capillary electrophoresis systems. IntegenX solutions include the Rapid HIT platforms, software analysis tools, and related consumables that are highly compatible with Thermo Fisher’s short tandem repeat (STR) chemistries for human identification.

IntegenX currently provides support to prosecutors and law enforcement in 17 countries where its technology is used in government laboratories to generate forensic DNA profiles from samples in 90 minutes as opposed to the standard processing time of 3 weeks. Such a dramatic reduction in time from sample to result has led to an increased demand from law-enforcement agencies, and aligns with their strategy to expand their leadership position in the human identification market.